Bon Secours Cancer Institute Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2003
NCT00063882
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Bon Secours Mercy Health

Active Ingredients

Drugs in Phase 3 Trials (2)

125-iodine (1 trial)

palladium (1 trial)

Drugs in Other Trials (1)

methylprednisolone (medrol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3